Insider Trading & Ownership - Fust Matthew K

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Fust Matthew K
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-10-17
Sale
2024-10-18
6:25 pm
Neumora Therapeutics Inc.NMRAFust Matthew K
Director
21,788$17.03$370,962205,321
(Direct)
View
2024-03-20
Sale
2024-03-22
4:31 pm
Crinetics Pharmaceuticals Inc.CRNXFust Matthew K
Director
60,000$44.14$2,648,15018,536
(Direct)
View
2024-03-07
Sale
2024-03-11
12:54 pm
Ultragenyx Pharmaceutical Inc.RAREFust Matthew K
Director
12,195$50.88$620,44314,860
(Direct)
View
2022-07-13
Sale
2022-07-15
4:30 pm
Crinetics Pharmaceuticals Inc.CRNXFust Matthew K
Director
5,700$20.96$119,45512,536
(Direct)
View
2021-11-04
Sale
2021-11-05
4:28 pm
Atara Biotherapeutics Inc.ATRAFust Matthew K
Director
13,354$19.5$260,40331,500
(Direct)
View
2021-11-01
Sale
2021-11-03
4:55 pm
Crinetics Pharmaceuticals Inc.CRNXFust Matthew K
Director
8,954$25.5$228,32724,628
(Direct)
View
2021-09-08
Sale
2021-09-09
5:00 pm
Crinetics Pharmaceuticals Inc.CRNXFust Matthew K
Director
6,046$25.5$154,17333,582
(Direct)
View
2021-07-26
Sale
2021-07-27
8:00 pm
Crinetics Pharmaceuticals Inc.CRNXFust Matthew K
Director
5,000$19.59$97,95039,628
(Direct)
View
2021-07-19
Sale
2021-07-20
5:00 pm
Crinetics Pharmaceuticals Inc.CRNXFust Matthew K
Director
5,000$19.5$97,50044,628
(Direct)
View
2021-07-12
Sale
2021-07-13
5:00 pm
Crinetics Pharmaceuticals Inc.CRNXFust Matthew K
Director
5,000$20.71$103,55049,628
(Direct)
View
2020-07-06
Sale
2020-07-08
12:30 pm
Ultragenyx Pharmaceutical Inc.RAREFust Matthew K
Director
6,181$90$556,29013,550
(Direct)
View
2020-07-01
Sale
2020-07-06
2:21 pm
Ultragenyx Pharmaceutical Inc.RAREFust Matthew K
Director
5,000$85$425,00019,731
(Direct)
View
2020-05-18
Sale
2020-05-19
7:13 pm
Ultragenyx Pharmaceutical Inc.RAREFust Matthew K
Director
1,875$75$140,62511,000
(Direct)
View
2020-04-22
Sale
2020-04-24
1:00 pm
Ultragenyx Pharmaceutical Inc.RAREFust Matthew K
Director
1,875$65$121,87512,875
(Direct)
View
2019-12-24
Sale
2019-12-26
4:13 pm
Dermira Inc.DERMFust Matthew K
Director
3,000$15$45,0005,051
(Direct)
View
2019-12-16
Sale
2019-12-18
6:32 pm
Crinetics Pharmaceuticals Inc.CRNXFust Matthew K
Director
3,500$22.5$78,75054,628
(Direct)
View
2019-12-12
Sale
2019-12-13
5:13 pm
Dermira Inc.DERMFust Matthew K
Director
3,000$12$36,0008,051
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-10-17
Exercise
2024-10-18
6:25 pm
N/A
2030-09-07
Neumora Therapeutics Inc.NMRAFust Matthew K
Director
21,788$0205,321
(Direct)
View
2024-10-17
Exercise
2024-10-18
6:25 pm
N/A
N/A
Neumora Therapeutics Inc.NMRAFust Matthew K
Director
10,000$2.52205,321
(Direct)
View
2024-10-17
Exercise
2024-10-18
6:25 pm
N/A
N/A
Neumora Therapeutics Inc.NMRAFust Matthew K
Director
3,783$8.32205,321
(Direct)
View
2024-10-17
Exercise
2024-10-18
6:25 pm
N/A
N/A
Neumora Therapeutics Inc.NMRAFust Matthew K
Director
8,005$8.79205,321
(Direct)
View
2024-06-18
Option Award
2024-06-20
2:26 pm
N/A
2034-06-18
Ultragenyx Pharmaceutical Inc.RAREFust Matthew K
Director
15,245$030,105
(Direct)
View
2024-06-13
Option Award
2024-06-14
4:13 pm
N/A
2034-06-12
Neumora Therapeutics Inc.NMRAFust Matthew K
Director
48,671$048,671
(Direct)
View
2024-06-07
Option Award
2024-06-11
4:19 pm
N/A
2034-06-07
Crinetics Pharmaceuticals Inc.CRNXFust Matthew K
Director
15,900$034,436
(Direct)
View
2024-03-31
Option Award
2024-04-02
6:13 pm
N/A
N/A
Atara Biotherapeutics Inc.ATRAFust Matthew K
Director
150,000$0259,000
(Direct)
View
2024-03-20
Exercise
2024-03-22
4:31 pm
N/A
2029-06-20
Crinetics Pharmaceuticals Inc.CRNXFust Matthew K
Director
60,000$018,536
(Direct)
View
2024-03-20
Exercise
2024-03-22
4:31 pm
N/A
N/A
Crinetics Pharmaceuticals Inc.CRNXFust Matthew K
Director
17,500$20.2318,536
(Direct)
View
2024-03-20
Exercise
2024-03-22
4:31 pm
N/A
N/A
Crinetics Pharmaceuticals Inc.CRNXFust Matthew K
Director
17,500$18.2918,536
(Direct)
View
2024-03-20
Exercise
2024-03-22
4:31 pm
N/A
N/A
Crinetics Pharmaceuticals Inc.CRNXFust Matthew K
Director
12,500$23.2418,536
(Direct)
View
2024-03-20
Exercise
2024-03-22
4:31 pm
N/A
N/A
Crinetics Pharmaceuticals Inc.CRNXFust Matthew K
Director
12,500$23.2318,536
(Direct)
View
2023-09-14
Option Award
2023-09-18
5:51 pm
N/A
2033-09-13
Neumora Therapeutics Inc.NMRAFust Matthew K
Director
27,802$027,802
(Direct)
View

Ownership
2023-09-14
6:57 pm
N/A
2030-09-07
Neumora Therapeutics Inc.NMRAFust Matthew K
Director
0$0107,374
(Direct)
View
2023-06-16
Option Award
2023-06-21
5:00 pm
N/A
2033-06-15
Crinetics Pharmaceuticals Inc.CRNXFust Matthew K
Director
23,500$036,036
(Direct)
View
2023-06-07
Option Award
2023-06-09
2:32 pm
N/A
2033-06-07
Ultragenyx Pharmaceutical Inc.RAREFust Matthew K
Director
10,970$034,165
(Direct)
View
2023-06-07
Disposition
2023-06-09
2:32 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREFust Matthew K
Director
3,300$51.8234,165
(Direct)
View
2023-05-31
Option Award
2023-06-02
7:09 pm
N/A
2033-05-30
Atara Biotherapeutics Inc.ATRAFust Matthew K
Director
136,500$0188,500
(Direct)
View
2022-07-13
Exercise
2022-07-15
4:30 pm
N/A
2027-11-05
Crinetics Pharmaceuticals Inc.CRNXFust Matthew K
Director
5,700$012,536
(Direct)
View
2022-07-13
Exercise
2022-07-15
4:30 pm
N/A
N/A
Crinetics Pharmaceuticals Inc.CRNXFust Matthew K
Director
5,700$1.4512,536
(Direct)
View
2022-06-24
Option Award
2022-06-28
1:52 pm
N/A
2032-06-24
Ultragenyx Pharmaceutical Inc.RAREFust Matthew K
Director
9,545$032,740
(Direct)
View
2022-06-23
Option Award
2022-06-27
4:48 pm
N/A
2032-06-22
Atara Biotherapeutics Inc.ATRAFust Matthew K
Director
52,000$083,500
(Direct)
View
2022-06-17
Option Award
2022-06-21
4:46 pm
N/A
2032-06-16
Crinetics Pharmaceuticals Inc.CRNXFust Matthew K
Director
17,500$017,500
(Direct)
View
2022-03-04
Exercise
2022-03-08
12:25 pm
N/A
2024-07-10
Ultragenyx Pharmaceutical Inc.RAREFust Matthew K
Director
7,500$023,195
(Direct)
View
2022-03-04
Exercise
2022-03-08
12:25 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREFust Matthew K
Director
7,500$40.3723,195
(Direct)
View
2021-11-01
Exercise
2021-11-03
4:55 pm
N/A
2028-03-16
Crinetics Pharmaceuticals Inc.CRNXFust Matthew K
Director
8,954$024,628
(Direct)
View
2021-11-01
Exercise
2021-11-03
4:55 pm
N/A
N/A
Crinetics Pharmaceuticals Inc.CRNXFust Matthew K
Director
8,954$1.9124,628
(Direct)
View
2021-09-08
Exercise
2021-09-09
5:00 pm
N/A
2028-03-16
Crinetics Pharmaceuticals Inc.CRNXFust Matthew K
Director
6,046$033,582
(Direct)
View
2021-09-08
Exercise
2021-09-09
5:00 pm
N/A
N/A
Crinetics Pharmaceuticals Inc.CRNXFust Matthew K
Director
6,046$1.9133,582
(Direct)
View
2021-07-26
Exercise
2021-07-27
8:00 pm
N/A
2028-03-16
Crinetics Pharmaceuticals Inc.CRNXFust Matthew K
Director
5,000$039,628
(Direct)
View
2021-07-26
Exercise
2021-07-27
8:00 pm
N/A
N/A
Crinetics Pharmaceuticals Inc.CRNXFust Matthew K
Director
5,000$1.9139,628
(Direct)
View
2021-07-19
Exercise
2021-07-20
5:00 pm
N/A
2028-03-16
Crinetics Pharmaceuticals Inc.CRNXFust Matthew K
Director
5,000$044,628
(Direct)
View
2021-07-19
Exercise
2021-07-20
5:00 pm
N/A
N/A
Crinetics Pharmaceuticals Inc.CRNXFust Matthew K
Director
5,000$1.9144,628
(Direct)
View
2021-07-12
Exercise
2021-07-13
5:00 pm
N/A
2028-03-16
Crinetics Pharmaceuticals Inc.CRNXFust Matthew K
Director
5,000$049,628
(Direct)
View
2021-07-12
Exercise
2021-07-13
5:00 pm
N/A
N/A
Crinetics Pharmaceuticals Inc.CRNXFust Matthew K
Director
5,000$1.9149,628
(Direct)
View
2021-06-24
Option Award
2021-06-28
6:24 pm
N/A
2031-06-24
Ultragenyx Pharmaceutical Inc.RAREFust Matthew K
Director
6,270$019,820
(Direct)
View
2021-06-22
Option Award
2021-06-23
5:00 pm
N/A
2031-06-21
Crinetics Pharmaceuticals Inc.CRNXFust Matthew K
Director
17,500$017,500
(Direct)
View
2021-06-08
Option Award
2021-06-09
7:05 pm
N/A
2031-06-07
Atara Biotherapeutics Inc.ATRAFust Matthew K
Director
28,500$062,354
(Direct)
View
2020-07-06
Exercise
2020-07-08
12:30 pm
N/A
2024-01-29
Ultragenyx Pharmaceutical Inc.RAREFust Matthew K
Director
6,181$013,550
(Direct)
View
2020-07-06
Exercise
2020-07-08
12:30 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREFust Matthew K
Director
6,181$2113,550
(Direct)
View
2020-07-01
Exercise
2020-07-06
2:21 pm
N/A
2024-01-29
Ultragenyx Pharmaceutical Inc.RAREFust Matthew K
Director
5,000$019,731
(Direct)
View
2020-07-01
Exercise
2020-07-06
2:21 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREFust Matthew K
Director
5,000$2119,731
(Direct)
View
2020-06-26
Option Award
2020-06-30
1:12 pm
N/A
2030-06-26
Ultragenyx Pharmaceutical Inc.RAREFust Matthew K
Director
6,800$017,800
(Direct)
View
2020-06-19
Option Award
2020-06-22
4:24 pm
N/A
2030-06-18
Crinetics Pharmaceuticals Inc.CRNXFust Matthew K
Director
12,500$012,500
(Direct)
View
2020-06-16
Option Award
2020-06-17
5:45 pm
N/A
2030-06-15
Atara Biotherapeutics Inc.ATRAFust Matthew K
Director
32,500$058,354
(Direct)
View
2020-02-20
Disposition
2020-02-24
7:32 pm
N/A
2024-06-05
Dermira Inc.DERMFust Matthew K
Director
55,912$00
(Direct)
View
2020-02-20
Disposition
2020-02-24
7:32 pm
N/A
N/A
Dermira Inc.DERMFust Matthew K
Director
5,051$18.750
(Direct)
View
2019-12-16
Exercise
2019-12-18
6:32 pm
N/A
2028-03-16
Crinetics Pharmaceuticals Inc.CRNXFust Matthew K
Director
3,500$054,628
(Direct)
View
2019-12-16
Exercise
2019-12-18
6:32 pm
N/A
N/A
Crinetics Pharmaceuticals Inc.CRNXFust Matthew K
Director
3,500$1.9154,628
(Direct)
View